SPDR S&P Pharmaceuticals ETF (XPH) News Today $43.27 +0.52 (+1.22%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 7:00 AM | marketbeat.comAstraZeneca Shares Fall Despite EPS Beat and Raised GuidanceAstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu.July 17, 2024 | marketbeat.comPharmaceutical Stocks - Best Pharmaceutical Stocks to Buy (XPH)Along with biotechnology and biotech companies, the pharma industry is a major part of the overall healthcare market. Pharmaceutical companies include some of the biggest stock gainers and some of the best growth stocks on the market. The pharmaceutical market has many amazing stocks to watch. The pharma industry may also be a good investment for those looking for dividend stocks since so many of the largest pharmaceutical companies pay a dividend to its shareholders. Though the industry has plenty of potential for growth, investors should also be aware that pharma stocks—especially smaller startups—can be risky. Investors buying pharma stocks should make sure to do their research and only invest in pharma stocks as part of a diversified portfolio.March 30, 2024 | finance.yahoo.comSPDR S&P Pharmaceuticals ETF (XPH)March 28, 2024 | seekingalpha.comXPH: A More Balanced Way To Get Exposure To PharmaceuticalsFebruary 16, 2024 | wsj.comSPDR S&P Pharmaceuticals ETFFebruary 5, 2024 | usatoday.comS&P 500 (SPX) today: Catalent Inc is a top mover, up 10%December 23, 2023 | benzinga.comSPDR S&P Pharmaceuticals ETF (ARCA:XPH), Quotes and News SummaryDecember 18, 2023 | msn.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1744November 6, 2023 | marketwatch.comWhy the S&P 500 ETF’s rare triple ‘gap ups’ isn’t a buy signalOctober 29, 2023 | investing.comXPH ETF Stock Price HistoryOctober 20, 2023 | thestreet.comETF Watch: Fortitude, Not Fashion Wins OutSeptember 18, 2023 | msn.comSPDR Portfolio Mid Cap ETF declares quarterly distribution of $0.1758September 1, 2023 | marketbeat.comHow Much Pain Will Lower Medicare Prices Cause for Pharma Stocks? (XPH)Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.June 25, 2023 | msn.comWhat is behind big pharma's underperformance?June 21, 2023 | msn.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1235May 31, 2023 | markets.businessinsider.comSPY ETF Gains 11% YTD: Technical Indicators Signal Further UpsideApril 12, 2023 | marketwatch.comWhen Spdr S&p Pharmaceuticals ($XPH) Moves Investors should ListenMarch 22, 2023 | seekingalpha.comXPH SPDR S&P Pharmaceuticals ETFJanuary 3, 2023 | seekingalpha.comSPYV: How Microsoft And Amazon Changed The S&P 500 Value IndexDecember 27, 2022 | seekingalpha.comEli Lilly: Right Industry, Wrong PriceDecember 19, 2022 | msn.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1940December 16, 2022 | msn.comSPDR S&P 500 ESG ETF declares quarterly distribution of $0.1728November 13, 2022 | seekingalpha.comXPH: U.S. Pharmaceuticals Stocks Are Probably Fairly Valued, Cyclically UnattractiveNovember 2, 2022 | msn.comChevron, Uber Technologies, And A Way To 'Bet Against The Big Guys' Are CNBC's 'Final Trades'October 1, 2022 | seekingalpha.comMDYG SPDR S&P 400 Mid Cap Growth ETFSeptember 21, 2022 | seekingalpha.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1320September 7, 2022 | thestreet.comDrug ETFs Likely Winners of Health LawSeptember 5, 2022 | thestreet.comObamacare Still Sickly, After All These YearsJuly 2, 2022 | thestreet.comSPDR S&P Pharmaceuticals ETF NewsMay 24, 2022 | theglobeandmail.comGordon Pape’s mailbag: Pharma ETFs, tax losses, undeclared capital gains and other investing questionsMay 3, 2022 | realmoney.thestreet.comIn a Sick Market, Can Pharmas Help?April 27, 2022 | nasdaq.com12.8% of XPH Holdings Seeing Recent Insider BuysMarch 18, 2022 | nasdaq.comInsiders Buy the Holdings of XPH ETFMarch 5, 2022 | seekingalpha.comViatris stands out amid selloff in generic drugmakersNovember 15, 2021 | nasdaq.comIs SPDRSP PHARMA (XPH) a Strong ETF Right Now?November 4, 2021 | nasdaq.comThursday's ETF with Unusual Volume: XPH Get SPDR S&P Pharmaceuticals ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter. Email Address We’re in a code red crisis and 99% of Americans are clueless (Ad)Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! XPH Media Mentions By Week XPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XPH News Sentiment▼0.530.77▲Average News Sentiment XPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XPH Articles This Week▼10▲XPH Articles Average Week Get SPDR S&P Pharmaceuticals ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Invesco S&P SmallCap Health Care ETF News Today Simplify Health Care ETF News Today Invesco Biotechnology & Genome ETF News Today ALPS Medical Breakthroughs ETF News Today ProShares Ultra Nasdaq Biotechnology News Today Invesco Nasdaq Biotechnology ETF News Today Principal Healthcare Innovators ETF News Today Langar Global HealthTech ETF News Today VanEck Biotech ETF News Today VanEck Pharmaceutical ETF News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:XPH) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
